Dr. Craig Thiessen Joins Singular Medical Technologies Board of Directors
West Houston Radiology Managing Partner Brings Deep Radiology Experience, Health Care Business Acumen
Winter Haven, FL – Singular Medical Technologies, an emerging medical software company focused on the design and development of solutions to streamline access to images from multiple Picture Archiving Communications Systems (“PACS”), announced today that Dr. Craig Thiessen, Managing Partner of West Houston Radiology, has joined the company’s board of directors.
“We couldn’t be more excited to have a luminary of Dr. Thiessen’s caliber join our board,” said Richard Prati, Executive Chairman of Singular Medical Technologies. “With more than three decades in the radiology industry, both as a radiologist and as an owner of a very successful radiology practice in Texas, he’ll be an invaluable resource as our clients globally continue to adopt our unique medical software.”
“We work with hospitals all over Texas and have been looking for a solution to our PACS incompatibility problems for more than a decade,” said Thiessen, who founded West Houston Radiology in 1991. “When we were introduced to Singular’s technology, I knew immediately it as an industry disruptor. Lots of companies make claims about what they can deliver. Singular is the only medical software company that actually has a single worklist solution that enables radiologists to read from multiple PACS easily and efficiently. That’s why I’m very pleased to join the board to help grow the company, fix radiology problems, enhance productivity and improve patient diagnoses and outcomes.”
“Seeing the enthusiasm from the physicians at West Houston Radiology when they used our solution was priceless” said Felix Garcia, CEO of Singular Medical Technologies. “Dr. Thiessen has built an amazing practice and assembled an outstanding team of radiologists; solving their compatibility issues and seeing their productivity improve is very professionally satisfying.”
With 40 years of experience in the medical field, Dr. Thiessen is a board-certified radiologist with more than 30 years in radiology and the last 10 as a breast specialist. He has seen breast imaging grow and change from xeromammography to film screen mammo to digital and onto tomosynthesis. His certifications include Diagnostic Radiology, American Board of Radiology and Fellow of Royal College of Physician and Surgeons of Canada. A regular guest lecturer at conferences around the world, Dr. Thiessen earned his undergraduate degree from the University of Manitoba and his medical degree from the University of Manitoba, Winnipeg, Manitoba. He lives in Houston.
About Singular Medical Technologies
Based in Winter Haven, FL, Singular Medical Technologies (SMT) is the only global medical software company with a single elegant solution to seamlessly integrate multiple disparate radiology PACS and dictation systems. The company designs and develops high-performance medical software for hospitals, imaging centers, radiology and cardiology groups around the country. The company’s innovative RADSOFT UNIFY solution allows physicians and health care professionals full and direct access to all PACS versions and worklists across entire health care networks, with an implementation schedule that continues to impress the industry. The technology addresses the global problem of incompatible PACS systems and does not have any of the constraints or complexities experienced by current cloud-based systems, overlays or VNAs. SMT also develops solutions for emergency rooms, teleradiology and high-performance mammography workstations. For more information, visit www.singmedtech.com.
Except for historical information, all statements, expectations and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: reliance on key personnel; the early stage of our business; risks associated with the development process; competition; and other risks described in other Company press releases and presentations. Singular Medical Technologies assumes no obligation and does not intend to update these forward-looking statements, except as required by law.